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boast authors who are experts in their fields, stand alone as comprehensive critiques of
the current technology or as organized, well-integrated sections of the complete
retrovirus body ofliterature.
Clinicians and basic researchers will appreciate the well-balanced coverage of
disease and molecular processes, the clear prose, the concise summaries, and, finally,
the comprehensive citation ofreferences at the end ofeach chapter. The only difficulty
with such a contemporary treatment is that much of the current data on HIV has
already become dated by the time of the book's publication. The volume is, however,
recommended for all those who wish to supplement their knowledge of retroviruses
whether it be from a current or historical perspective, particularly those who need a
valuable, readily readable resource for later reference.
MAY C. CHEN
MedicalStudent
Yale UniverstiySchoolofMedicine
ACYCLOVIR THERAPY FOR HERPESVIRUS INFECTIONS. Edited by David A. Baker. New
York, Marcel Dekker, Inc., 1990. 323 pp. $99.75.
This multi-authored text, composed of 17 chapters relating to the antiviral agent
acyclovir (ACV), is the fourth volume of a series, Infectious Disease and Therapy,
edited by B.E. Scully and H.C. Neu. ACV [9-(2-hydroxyethoxymethyl) guanine] is a
synthetic nucleoside analogue with considerable antiviral activity against members of
the Herpesvirus group.
Acyclovir was introduced in 1982 as a topical agent and in 1983 for intravenous use.
Like other antiviral agents, as well as anti-cancer agents, its use relies on the principle
of "selective toxicity." In other words, the drug is active against the virus in the
infected cell, and the adjacent normal cells are spared drug toxicity. This agent is more
virus-specific than previously available antivirals because it is activated mainly by a
virus-specific thymidine kinase and then acts as an inhibitor of a viral DNA poly-
merase. Its lack of systemic toxicity in the host has resulted in a leap forward in the
treatment of infections due to herpes simplex virus (HSV) and varicella zoster virus
(VZV). (It is less effective against Epstein-Barr virus [EBV] and not useful for
cytomegalovirus [CMV] infections.) The importance of infections due to these viral
agents and the fact that acyclovir has become the drug of choice make this book a
reasonable resource for a clinical infectious disease specialist.
The book contains background chapters on the molecular biology, toxicity, and
pharmacology of ACV. The bulk of the volume is therapy-oriented and arranged by
specific viral agents and herpesvirus-caused diseases. There is appropriate emphasis
throughout on the immunocompromised host. These chapters are written by clinical
research specialists, each ofwhom is recognized as having authored the major clinical
studies in the field. Having Whitley write on HSV, Feldman on VZV, Arvin on
pediatric pharmacology, and Straus on EBV means that the text includes truly
authoritative reviews on the clinical studies of ACV use. Each of these chapters
provides a comprehensive review ofpublished studies. The twochaptersco-authored by
Richard Whitley, one on HSV encephalitis and the other on neonatal HSV infections,
are outstanding and carefully synthesize material from dozens of studies. Other
chapters on the useofACV in pregnancy, in infections ofthe eye, and in genital herpes
provide specialized information not available in general reviews ofthe drug.262 BOOK REVIEWS
A generally compact style ofpresentation and fairly good indexing make looking up
specific information quite easy. Overlap between chapters is inevitable but is held to a
reasonable minimum. The major problem is timeliness. This book has a copyright date
of 1990, but it was available in late 1989. Few references appear for publications later
than 1987. This subject is a rapidly developing field, and studies published in 1990
already require that some of the opinions in the book be modified. After 1990, the
volume will best be used for background, prior to a review ofthe current literature. For
now I can recommend it toan infectiousdiseasespecialist, fellow, orstudentlooking for
reasonably up-to-date information, but it may be a purchase with a short "shelflife."
ROBERT S. BALTIMORE
Departments ofPediatrics andEpidemiology andPublicHealth
Yale University SchoolofMedicine
GROWTH FACTORS AND THEIR RECEPTORS: GENETIC CONTROL AND RATIONAL APPLI-
CATION. Edited by Russell Ross, Anthony W. Burgess, and Tony Hunter. New York,
Alan R. Liss, Inc., 1989. 319 pp. $120.00.
This volume comprises a selection of papers derived from a UCLA Keystone
symposium, held from January 24-January 30, 1988. A wide-ranging selection of
up-to-date research reports, these papers provide an excellent sampling ofthe "state of
the art" in growth factor research as of 1988. The papers are, in general, clear and well
written, reviewing topical background material, describing methodology, and present-
ing clearly analyzed and important data. The quality of the figures on glossy paper is
excellent, both for line drawings and photographs.
Contrary to thejacket copy (which suggests thatthis is a bookabout platelet-derived
growth factor only), the volume touches on virtually all of the significant growth
factors under current study, including fibroblast growth factor, epidermal growth
factor, bombesin, insulin, transforming growth factor beta, and the hematopoietic
growth factors. Factor biochemistry, receptor interactions, intracellular signal trans-
duction, and growth factoreffects are all explored. Achapteron clinical applications of
hematopoietic growth factors is particularly welcome in a scientific volume ofthis sort
and displays the great clinical promise offered by research in this field. References are
current and comprehensive, and thepapers areuniformly well edited. For the neophyte
to the field, therefore, this volume provides an excellent introduction, assisted by a
well-prepared index.
The more sophisticated student of growth factors should be aware (as the editors
note) that about two-thirds of the text is reprinted from the Journal of Cellular
Biochemistry. Although this fact is a potential concern with a volume ofthis price, it is
useful to havethis material all in oneplace. Theoriginal material in theotherone-third
of the volume maintains the editorial standards of the first two-thirds. An annoying,
although not fatal, aspect ofthe organization ofthe volume is the way the papers have
been assembled. The tableofcontents categorizes themanuscripts in a way thatinvites
browsing, but the papers are actually printed in the order oftheirjournal publication,
which does not correspond to theirorder or grouping in the tableofcontents and makes
it difficult to progress easily between papers on similar subjects.
In summary, despite some organizational drawbacks, this book will be highly useful
for a new student trying to survey the field of growth factors and their receptors. A
regular reader oftheJournalofCellularBiochemistry who hasclipped and filed many